|
|
|
Insider
Information: |
Henneman John B III |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
263,813 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,781,284 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
263,813 |
|
|
Total
Value |
$3,781,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-27.9%
|
-30.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Integra Lifesciences Holdings Corp |
IART |
CorpVP, CAO |
2014-08-25 |
34,159 |
2003-07-14 |
0 |
Premium* |
|
Lumos Pharma Inc |
LUMO |
Chief Administrative O... |
2018-10-01 |
55,052 |
2014-10-01 |
0 |
Premium* |
|
Seaspine Holdings Corp |
SPNE |
Director |
2023-01-05 |
0 |
2016-06-07 |
0 |
Premium* |
|
R1 RCM Inc |
ACHI |
Director |
2022-06-21 |
0 |
2016-08-16 |
0 |
Premium* |
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-03-13 |
8,139 |
2019-10-07 |
0 |
Premium* |
|
Anika Therapeutics Inc |
ANIK |
Director |
2023-06-14 |
29,936 |
2020-09-03 |
0 |
Premium* |
|
R1 Rcm Inc |
RCM |
Director |
2024-05-23 |
87,765 |
2022-06-21 |
0 |
Premium* |
|
Orthofix International N.V. |
OFIX |
Director |
2023-01-05 |
48,762 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
168 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2003-12-08 |
4 |
OE |
$4.38 |
$17,500 |
D/D |
4,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2004-01-12 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2004-02-09 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. V.P. CAO & Secretary |
|
2004-03-08 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, Secretary |
|
2004-04-12 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, Secretary |
|
2004-05-10 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2004-06-14 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2004-07-12 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
30,428 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec.VP, CAO & Secretary |
|
2004-08-09 |
4 |
OE |
$4.38 |
$67,047 |
D/D |
15,325 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. V.P., CAO, & Secretary |
|
2005-06-01 |
4 |
OE |
$5.50 |
$55,000 |
D/D |
10,000 |
41,925 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, & Secretary |
|
2005-11-28 |
4 |
OE |
$5.88 |
$36,090 |
D/D |
6,143 |
38,068 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec VP, CAO, & Secretary |
|
2005-12-15 |
4 |
OE |
$5.88 |
$108,200 |
D/D |
18,417 |
56,485 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
Exec VP, CAO, & Secretary |
|
2006-01-06 |
4/A |
OE |
$6.56 |
$32,813 |
D/D |
5,000 |
40,119 |
|
- |
|
IART |
Integra Lifesciences Hold... |
officerTitle |
|
2006-01-06 |
4 |
OE |
$6.56 |
$32,813 |
D/D |
5,000 |
39,423 |
|
- |
|
APRE |
Aprea Therapeutics, Inc. |
Director |
|
2024-03-13 |
4 |
B |
$7.29 |
$50,009 |
D/D |
6,860 |
8,139 |
2.39 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2018-01-02 |
4 |
D |
$8.47 |
$1,389 |
D/D |
(164) |
58,859 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2018-01-04 |
4 |
D |
$10.06 |
$13,309 |
D/D |
(1,323) |
57,536 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2017-10-01 |
4 |
D |
$10.18 |
$28,392 |
D/D |
(2,789) |
56,544 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2017-01-03 |
4 |
D |
$10.28 |
$1,686 |
D/D |
(164) |
59,935 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2017-01-04 |
4 |
D |
$11.04 |
$14,606 |
D/D |
(1,323) |
58,612 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2018-06-13 |
4 |
OE |
$12.44 |
$216,431 |
D/D |
17,398 |
64,708 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
Exec VP, CAO, & Secretary |
|
2006-03-15 |
4 |
OE |
$13.63 |
$26,283 |
D/D |
1,929 |
42,048 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP and CAO |
|
2006-11-16 |
4 |
OE |
$13.63 |
$246,217 |
D/D |
18,071 |
33,643 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2018-08-28 |
4 |
S |
$14.65 |
$29,725 |
D/D |
(2,029) |
58,115 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2018-08-29 |
4 |
S |
$14.65 |
$49,913 |
D/D |
(3,407) |
54,708 |
0 |
- |
|
168 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|